Its involvement in inflammation, airway damage, and steroid insensitivity underscores its importance in the pathogenesis of difficult-to-treat asthma and implies that modulating IFN-γ or its downstream effects could represent a potential therapeutic approach for certain patient populations [45]. The gene discussed is IFNG; the disease is asthma.